Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.23.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of reportable business segment information
Reportable business segment information is as follows (dollar amounts in thousands):

  Three Months Ended
March 31,
  2023 2022
Net sales:    
Asia $ 46,345  $ 46,110 
Europe 21,405  21,777 
North America 34,648  35,981 
Latin America and Other 6,236  6,626 
Total net sales 108,634  110,494 
Contribution margin (1):    
Asia 21,951  21,939 
Europe 6,536  4,373 
North America 12,861  12,719 
Latin America and Other 2,466  2,901 
Total contribution margin 43,814  41,932 
Selling, general and administrative expenses (2) 43,642  40,623 
Operating income 172  1,309 
Other loss, net 1,514  (314)
Income before provision for income taxes $ 1,686  $ 995 
_________________________________________

(1)    Contribution margin consists of net sales less cost of sales and volume incentives expense.
(2)    Service fees in China totaled $3.7 million and $4.9 million for the three-month periods ended March 31, 2023 and 2022, respectively. These service fees are included in selling, general and administrative expenses.
Schedule of consolidated net sales revenue by geographical locations
From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three-month periods ended March 31, 2023 and 2022, as follows (dollar amounts in thousands):
 
  Three Months Ended
March 31,
  2023 2022
Net sales:    
United States $ 31,986  $ 33,229 
Taiwan 14,175  9,750 
South Korea 11,240  13,653 
Other 51,233  53,862 
  $ 108,634  $ 110,494 
Schedule of revenue generated by each of the Company's product lines
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
 
  Three Months Ended
March 31,
  2023 2022
Asia    
General health $ 13,764  $ 12,986 
Immune 462  1,344 
Cardiovascular 14,895  13,630 
Digestive 9,422  9,036 
Personal care 1,341  2,543 
Weight management 6,461  6,571 
  46,345  46,110 
Europe    
General health $ 9,174  $ 9,196 
Immune 2,284  2,631 
Cardiovascular 2,519  2,633 
Digestive 5,738  5,591 
Personal care 1,177  1,233 
Weight management 513  493 
  21,405  21,777 
North America    
General health $ 15,534  $ 15,314 
Immune 4,320  4,872 
Cardiovascular 3,588  3,842 
Digestive 8,731  8,594 
Personal care 1,464  2,175 
Weight management 1,011  1,184 
  34,648  35,981 
Latin America and Other    
General health $ 1,637  $ 1,818 
Immune 744  761 
Cardiovascular 466  357 
Digestive 2,885  2,841 
Personal care 351  641 
Weight management 153  208 
  6,236  6,626 
  $ 108,634  $ 110,494 
Schedule of consolidated property, plant and equipment by geographical locations
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
  March 31,
2023		 December 31,
2022
Property, plant and equipment:    
United States $ 42,424  $ 42,389 
Other 3,656  3,773 
Total property, plant and equipment, net $ 46,080  $ 46,162 
Schedule of assets per segment
Total assets per segment is set forth below (dollar amounts in thousands):
March 31,
2023		 December 31,
2022
Assets:    
Asia $ 100,592  $ 95,362 
Europe 18,610  15,773 
North America 107,507  112,319 
Latin America and Other 7,875  6,324 
Total assets $ 234,584  $ 229,778